These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Provascular strategy: targeting functional adaptations of mature blood vessels in tumors to selectively influence the tumor vascular reactivity and improve cancer treatment. Sonveaux P Radiother Oncol; 2008 Mar; 86(3):300-13. PubMed ID: 18313779 [TBL] [Abstract][Full Text] [Related]
9. Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies. Leite de Oliveira R; Hamm A; Mazzone M Mol Aspects Med; 2011 Apr; 32(2):71-87. PubMed ID: 21540050 [TBL] [Abstract][Full Text] [Related]
10. Vasculature and microenvironmental gradients: the missing links in novel approaches to cancer therapy? Denekamp J; Daşu A; Waites A Adv Enzyme Regul; 1998; 38():281-99. PubMed ID: 9762359 [TBL] [Abstract][Full Text] [Related]
11. Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: a rational advance? Choy H; Milas L J Natl Cancer Inst; 2003 Oct; 95(19):1440-52. PubMed ID: 14519750 [TBL] [Abstract][Full Text] [Related]
12. Vascular strategies for enhancing tumour response to radiation therapy. El Kaffas A; Tran W; Czarnota GJ Technol Cancer Res Treat; 2012 Oct; 11(5):421-32. PubMed ID: 22568629 [TBL] [Abstract][Full Text] [Related]
13. Tumor angiogenesis and vascular normalization: alternative therapeutic targets. Viallard C; Larrivée B Angiogenesis; 2017 Nov; 20(4):409-426. PubMed ID: 28660302 [TBL] [Abstract][Full Text] [Related]
14. Improving tumor response to radiotherapy by targeting angiogenesis signaling pathways. Wachsberger P; Burd R; Dicker AP Hematol Oncol Clin North Am; 2004 Oct; 18(5):1039-57, viii. PubMed ID: 15474334 [TBL] [Abstract][Full Text] [Related]
15. The impact of including spatially longitudinal heterogeneities of vessel oxygen content and vascular fraction in 3D tumor oxygenation models on predicted radiation sensitivity. Lagerlöf JH; Kindblom J; Bernhardt P Med Phys; 2014 Apr; 41(4):044101. PubMed ID: 24694162 [TBL] [Abstract][Full Text] [Related]
16. [Angiogenesis inhibitors and radiotherapy]. Riesterer O Praxis (Bern 1994); 2012 Aug; 101(16):1031-7. PubMed ID: 22878946 [TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic therapy: creating a unique "window" of opportunity. Lin MI; Sessa WC Cancer Cell; 2004 Dec; 6(6):529-31. PubMed ID: 15607955 [TBL] [Abstract][Full Text] [Related]
18. Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies. Horsman MR; Siemann DW Cancer Res; 2006 Dec; 66(24):11520-39. PubMed ID: 17178843 [TBL] [Abstract][Full Text] [Related]